Nanoscopix is an ongoing research project owned by Life Science Inkubator Sachsen GmbH & Co. KG, a subsidiary of Life Science Inkubator GmbH (LSI), which is headquartered in Bonn. LSI promotes innovative research projects in the fields of biotechnology, pharmaceuticals and medical engineering for periods of up to three years, and continues development jointly with the project groups until products are ready for market or funding. Constituted by a public-private partnership between the federal government, the state of Northrhine-Westphalia, research institutions and private investors, the concept is the only one of its kind in the Federal Republic.
Under the leadership of Dr. Kay Großmann, the Nanoscopix team was originally formed at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) to develop cryo-fluorescence procedures and use them to design and build a low-temperature measuring cell as an expansion module for standard fluorescence microscopy. The expansion module will be developed under the name ‘ Cryo Micro Station‘ (CMS)’ under the auspices of the LSI project until a prototype ready for series production is completed.
Key data for the first round of financing
The LSI research project will end in the second half of 2016. Before that time, the Nanoscopix team intends to found a spin-off company with equity owner participation.
We will be delighted to present our business plan to prospective investors for inspection. Our equity capital requirement is approximately EUR 0.5 million for a period of 2 years.
[Last update 03/2016]